Can this tool determine a final FDA pathway?

No. This tool is for planning and triage only. Final pathway decisions require qualified regulatory judgment and current FDA policy review for the specific device facts.

When does a Traditional 510(k) usually fit best?

Traditional 510(k) is often the practical default when there is a potentially suitable predicate, but modifications or risk profile require a full evidence package rather than a narrower Special 510(k) approach.

What should teams do if no suitable predicate is found?

If no legally marketed suitable predicate is identified, teams should evaluate De Novo strategy and request expert review before spending heavily on a Traditional 510(k) package.

FDA 510(k) Pathway Decision Tool

This decision tool helps device teams triage likely pathway fit before committing to a full submission build. It scores predicate fit, change profile, and evidence readiness to indicate whether you should treat the project as likely Traditional 510(k), potentially Special 510(k), potentially Abbreviated 510(k), or a likely De Novo/PMA escalation check.

Need end-to-end 510(k) execution after triage?

Use Cruxi's full workflow for classification, predicate analysis, RTA-focused planning, and eSTAR packaging.

Go to 510(k) Submission Services

Interactive Pathway Triage Calculator

Project signal inputs

Choose the closest match for your current project. Then run triage to see pathway recommendation, confidence band, and next action.

Predicate fit quality

Change complexity profile

Special 510(k) fit

Consensus standards leverage

Evidence readiness

Run the calculator to view pathway fit and next-step guidance.

How to Use the Output

Suggested Track	What It Usually Means	Immediate Next Step
Special 510(k) candidate	Modification case may align if design controls and performance data support streamlined rationale.	Validate eligibility assumptions with a focused Special 510(k) checklist review before locking plan.
Traditional 510(k) default	Most common pathway when predicate exists but full evidence package and detailed SE narrative are still needed.	Build section-by-section evidence matrix and run an RTA-focused precheck before drafting eSTAR.
Abbreviated-leaning strategy	Project may benefit from stronger standards-centered structure where applicable.	Confirm applicable recognized standards strategy and map declarations/test reports to eSTAR sections.
Escalation risk (De Novo/PMA check)	Predicate strategy or risk profile may be too weak for efficient 510(k) execution.	Pause full 510(k) build, run deeper classification/predicate review, and evaluate alternate pathway timing.

Practical Planning Checklist

Document intended use and indications language in final-form wording before pathway commitment.
Capture predicate shortlist with explicit "same vs different" rationale fields.
Map each likely eSTAR section to current evidence status (ready, partial, missing).
Identify critical tests with external lab dependencies and expected lead times.
Pre-assign owners for SE narrative, test integration, and final quality review.

Pathway Scenario Impact Estimator

Compare pathway plan exposure before committing budget

Use this estimator to model likely timeline and cost exposure if your project is executed as Traditional, Special, or Abbreviated 510(k).

Program spend per week (USD)

Expected AI response cycle length (weeks)

Estimated major rework probability (%)

Expected external testing lag (weeks)

Planning model only. Inputs should be tuned to your actual scope and vendor constraints.

Run the estimator to compare timeline and cost exposure across likely pathway plans.

Q-Sub Need Estimator (Before Filing)

Estimate whether a pre-submission interaction is likely worth the delay

Use this model when your team is debating whether to file directly or run a focused Q-Sub first to reduce pathway, test, or endpoint uncertainty.

Technology novelty risk

Indications/use ambiguity

Test strategy uncertainty

Commercial timeline sensitivity

Internal regulatory depth

Run the estimator to view whether Q-Sub is likely warranted before filing.

Related 510(k) Tools

Primary References

FDA. How to Study and Market Your Device.
FDA. Overview of Device Regulation.
FDA. How to Prepare a Traditional 510(k).
FDA. How to Prepare a Special 510(k).
FDA. How to Prepare an Abbreviated 510(k).
FDA. 510(k) Submissions and eSTAR.
FDA. Q-Submission Program Guidance.

Important Use Note

This tool is designed for planning efficiency and risk triage. It is not legal advice and not an FDA determination. Treat results as a structured starting point for your internal regulatory review process.